JP5659010B2 - イソホスホルアミドマスタードの塩およびそれらの類似体 - Google Patents

イソホスホルアミドマスタードの塩およびそれらの類似体 Download PDF

Info

Publication number
JP5659010B2
JP5659010B2 JP2010502149A JP2010502149A JP5659010B2 JP 5659010 B2 JP5659010 B2 JP 5659010B2 JP 2010502149 A JP2010502149 A JP 2010502149A JP 2010502149 A JP2010502149 A JP 2010502149A JP 5659010 B2 JP5659010 B2 JP 5659010B2
Authority
JP
Japan
Prior art keywords
ipm
tris
dose
tumor
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010502149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523571A5 (cg-RX-API-DMAC7.html
JP2010523571A (ja
Inventor
ジョン シー. アメディオ,
ジョン シー. アメディオ,
バーバラ ピー. ウォルナー,
バーバラ ピー. ウォルナー,
フィリップ ビー. コマルニツキー,
フィリップ ビー. コマルニツキー,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ziopharm Oncology Inc
Original Assignee
Ziopharm Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39387443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5659010(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ziopharm Oncology Inc filed Critical Ziopharm Oncology Inc
Publication of JP2010523571A publication Critical patent/JP2010523571A/ja
Publication of JP2010523571A5 publication Critical patent/JP2010523571A5/ja
Application granted granted Critical
Publication of JP5659010B2 publication Critical patent/JP5659010B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
JP2010502149A 2007-04-06 2008-04-04 イソホスホルアミドマスタードの塩およびそれらの類似体 Expired - Fee Related JP5659010B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US92214807P 2007-04-06 2007-04-06
US60/922,148 2007-04-06
US92736307P 2007-05-02 2007-05-02
US60/927,363 2007-05-02
US93491407P 2007-06-15 2007-06-15
US60/934,914 2007-06-15
US123707P 2007-10-30 2007-10-30
US61/001,237 2007-10-30
PCT/US2008/004449 WO2008124097A2 (en) 2007-04-06 2008-04-04 Salts of isophosphoramide mustard and analogs thereof

Publications (3)

Publication Number Publication Date
JP2010523571A JP2010523571A (ja) 2010-07-15
JP2010523571A5 JP2010523571A5 (cg-RX-API-DMAC7.html) 2012-05-31
JP5659010B2 true JP5659010B2 (ja) 2015-01-28

Family

ID=39387443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502149A Expired - Fee Related JP5659010B2 (ja) 2007-04-06 2008-04-04 イソホスホルアミドマスタードの塩およびそれらの類似体

Country Status (22)

Country Link
US (2) US8604007B2 (cg-RX-API-DMAC7.html)
EP (2) EP2155682B1 (cg-RX-API-DMAC7.html)
JP (1) JP5659010B2 (cg-RX-API-DMAC7.html)
KR (3) KR20150139620A (cg-RX-API-DMAC7.html)
CN (2) CN102942589B (cg-RX-API-DMAC7.html)
AU (1) AU2008236684B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809999A2 (cg-RX-API-DMAC7.html)
CA (1) CA2684747A1 (cg-RX-API-DMAC7.html)
CY (1) CY1116596T1 (cg-RX-API-DMAC7.html)
DK (2) DK2155682T3 (cg-RX-API-DMAC7.html)
ES (1) ES2547302T3 (cg-RX-API-DMAC7.html)
HU (1) HUE025949T2 (cg-RX-API-DMAC7.html)
IL (2) IL201424A (cg-RX-API-DMAC7.html)
MX (1) MX2009010820A (cg-RX-API-DMAC7.html)
NZ (1) NZ580341A (cg-RX-API-DMAC7.html)
PL (1) PL2155682T3 (cg-RX-API-DMAC7.html)
PT (2) PT2581367E (cg-RX-API-DMAC7.html)
RU (1) RU2527531C2 (cg-RX-API-DMAC7.html)
SI (1) SI2155682T1 (cg-RX-API-DMAC7.html)
TW (2) TWI490226B (cg-RX-API-DMAC7.html)
WO (1) WO2008124097A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907722B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) * 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2010099213A1 (en) * 2009-02-24 2010-09-02 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
US20130196000A1 (en) * 2012-01-31 2013-08-01 Ziopharm Oncology, Inc. Combination therapy including isophosphoramide mustard, analogs, or salts thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (cg-RX-API-DMAC7.html) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide
US5091552A (en) 1986-06-30 1992-02-25 Board Of Regents, The University Of Texas System Novel antitumor aldophosphamide analogs
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
US5204335A (en) * 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5659061A (en) * 1995-04-20 1997-08-19 Drug Innovation & Design, Inc. Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities
DK0795334T3 (da) * 1996-03-12 2006-06-06 Sanofi Aventis Deutschland Nye prodrugs til behandling af tumorer og betændelsessygdomme
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체

Also Published As

Publication number Publication date
CN101679265B (zh) 2014-10-29
EP2581367A2 (en) 2013-04-17
SI2155682T1 (sl) 2015-11-30
CN102942589B (zh) 2016-04-20
TWI501972B (zh) 2015-10-01
WO2008124097A2 (en) 2008-10-16
CA2684747A1 (en) 2008-10-16
HUE025949T2 (en) 2016-05-30
EP2581367A3 (en) 2013-07-03
US20080255056A1 (en) 2008-10-16
US9340563B2 (en) 2016-05-17
KR101505415B1 (ko) 2015-03-25
MX2009010820A (es) 2010-03-18
EP2155682A2 (en) 2010-02-24
IL223353A (en) 2016-02-29
KR20150139620A (ko) 2015-12-11
RU2527531C2 (ru) 2014-09-10
EP2581367B1 (en) 2015-12-30
IL201424A0 (en) 2010-05-31
AU2008236684A1 (en) 2008-10-16
AU2008236684B2 (en) 2013-04-18
TW200906842A (en) 2009-02-16
WO2008124097A3 (en) 2008-12-24
KR101604244B1 (ko) 2016-03-17
US20140194377A1 (en) 2014-07-10
PT2155682E (pt) 2015-10-15
TWI490226B (zh) 2015-07-01
BRPI0809999A2 (pt) 2014-10-14
IL201424A (en) 2016-02-29
PT2581367E (pt) 2016-03-28
ZA200907722B (en) 2010-11-24
RU2009140904A (ru) 2011-05-20
DK2581367T3 (en) 2016-03-14
CN102942589A (zh) 2013-02-27
DK2155682T3 (en) 2015-09-21
IL223353A0 (en) 2013-02-03
US8604007B2 (en) 2013-12-10
CN101679265A (zh) 2010-03-24
TW201406772A (zh) 2014-02-16
KR20130041391A (ko) 2013-04-24
CY1116596T1 (el) 2017-03-15
NZ580341A (en) 2012-06-29
EP2155682B1 (en) 2015-06-24
PL2155682T3 (pl) 2015-12-31
JP2010523571A (ja) 2010-07-15
ES2547302T3 (es) 2015-10-05
KR20090130098A (ko) 2009-12-17

Similar Documents

Publication Publication Date Title
HK1209752A1 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US9340563B2 (en) Salts of isophosphoramide mustard and analogs thereof
ES2565069T3 (es) Sales de mostaza de isofosforamida y análogos de las mismas
US8124596B2 (en) Demethylpenclomedine analogs and their use as anti-cancer agents
JP5779106B2 (ja) 抗腫瘍剤としての4−ヒドロペルオキシイホスファミドの錯体
HK1185884A (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1100945B (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110401

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120329

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140519

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141201

R150 Certificate of patent or registration of utility model

Ref document number: 5659010

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees